Trials / Terminated
TerminatedNCT00432341
Efficacy and Safety of Two Different Botulinum Toxin Type A Treatments for Moderate to Severe Cervical Dystonia
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 54 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare two types of botulinum toxin type A to treat the involuntary muscle contractions in the neck
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | botulinum toxin type A | 200 Units at Visit 1 (Day 1) |
| BIOLOGICAL | botulinum toxin type A | 500 Units at Visit 1 (Day 1) |
Timeline
- Start date
- 2007-06-01
- Primary completion
- 2009-03-01
- Completion
- 2009-06-01
- First posted
- 2007-02-07
- Last updated
- 2011-12-16
- Results posted
- 2011-12-16
Locations
3 sites across 3 countries: Argentina, Australia, India
Source: ClinicalTrials.gov record NCT00432341. Inclusion in this directory is not an endorsement.